Middlebrook Pharma adds 271 reps

Share this article:
Westlake, Texas-based MiddleBrook Pharmaceuticals, Inc. has completed the hiring of its 271-person nationwide field sales force. The 271 territory managers comprising MiddleBrook's field sales force will begin educating healthcare professionals on the benefits of Moxatag (extended-release amoxicillin) tablets, 775 mg—a once-daily amoxicillin that was approved by the FDA on Jan. 23, 2009.

According to Middlebrook officials, MiddleBrook's territories have been structured to maximize the 271-person field sales force's ability to detail healthcare professionals nationwide, including pharmacists. The field force's efforts will be supported by a print media campaign targeted at healthcare professionals. 

John Thievon, president and CEO of MiddleBrook  said, “MiddleBrook's field sales force will be talking to physicians and pharmacists across the country about the benefits of Moxatag, patient convenience, improved compliance and a lower overall daily dose.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?